Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-18

FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ALPHAGAN P (brimonidine tartrate) from Allergan, Inc., regarding labeling changes. The product is used to treat open…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALPHAGAN P (BRIMONIDINE TARTRATE)

Snippet

SUPPL AP for ALPHAGAN P (BRIMONIDINE TARTRATE)